Skip to main content
Erschienen in: Pediatric Cardiology 7/2015

01.10.2015 | Original Article

The A1298C Methylenetetrahydrofolate Reductase Gene Variant as a Susceptibility Gene for Non-Syndromic Conotruncal Heart Defects in an Indian Population

verfasst von: Teena Koshy, Vettriselvi Venkatesan, Venkatachalam Perumal, Sridevi Hegde, Solomon Franklin Durairaj Paul

Erschienen in: Pediatric Cardiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Conotruncal heart defects (CTHDS) are a subgroup of congenital heart malformations that are considered to be a folate-sensitive birth defect. It has been hypothesized that polymorphisms in genes that code for key enzymes in the folate pathway may alter enzyme activity, leading to disruptions in folate metabolism and thus may influence the risk of such heart defects. This study was designed to investigate the association of six selected folate-metabolizing gene polymorphisms with the risk of non-syndromic CTHDs in an Indian population. This was a case–control study involving 96 cases of CTHDs and 100 control samples, ranging in age from birth to 18 years. Genotyping using Sanger sequencing was performed for six single nucleotide polymorphisms of genes involved in folate metabolism. Logistic regression analyses revealed that for the 5,10-methylenetetrahydrofolate (MTHFR) A1298C polymorphism, the CC variant homozygote genotype was associated with a significantly increased risk of CTHDs. The results of this study support an association between the inherited MTHFR A1298C genotype and the risk of CTHDs in an Indian population.
Literatur
1.
Zurück zum Zitat Anaclerio S, Di Ciommo V, Michielon G et al (2004) Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J 5(8):624PubMed Anaclerio S, Di Ciommo V, Michielon G et al (2004) Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J 5(8):624PubMed
2.
Zurück zum Zitat Bailey LB, Berry RJ (2005) Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 81:S1213–S1217 Bailey LB, Berry RJ (2005) Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 81:S1213–S1217
3.
Zurück zum Zitat Botto LD, Khoury MJ, Mulinare J et al (1996) Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based case-control study. Ped 98:911–917 Botto LD, Khoury MJ, Mulinare J et al (1996) Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based case-control study. Ped 98:911–917
4.
Zurück zum Zitat Botto LD, Correa A, Erickson JD (2001) Racial and temporal variations in the prevalence of heart defects. Ped 107:E32CrossRef Botto LD, Correa A, Erickson JD (2001) Racial and temporal variations in the prevalence of heart defects. Ped 107:E32CrossRef
5.
Zurück zum Zitat Cheng J, Zhu WL, Dao JJ et al (2005) Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed Env Sci 18:58–64 Cheng J, Zhu WL, Dao JJ et al (2005) Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed Env Sci 18:58–64
6.
Zurück zum Zitat Christensen KE, Zada YF, Rohlicek CV et al (2013) Risk of congenital heart defects is influenced by genetic variation in folate metabolism. Cardiol Young 23(01):89–98CrossRefPubMed Christensen KE, Zada YF, Rohlicek CV et al (2013) Risk of congenital heart defects is influenced by genetic variation in folate metabolism. Cardiol Young 23(01):89–98CrossRefPubMed
7.
Zurück zum Zitat Deeparani T, Pillai MR, Elavazhagan T (2009) Detection of MTHFR C677T and A1298C Gene Polymorphism in Congenital Heart Disease. Midd-East J Sci Res 4(2):127–132 Deeparani T, Pillai MR, Elavazhagan T (2009) Detection of MTHFR C677T and A1298C Gene Polymorphism in Congenital Heart Disease. Midd-East J Sci Res 4(2):127–132
8.
Zurück zum Zitat Galbiatti ALS, Ruiz MT, Biselli-Chicote PM et al (2010) Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer. Bra J Med Bio Res 43:445–450CrossRef Galbiatti ALS, Ruiz MT, Biselli-Chicote PM et al (2010) Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer. Bra J Med Bio Res 43:445–450CrossRef
9.
Zurück zum Zitat Galdieri LC, Arrieta SR, Silva CM et al (2007) Homocysteine concentrations and molecular analysis in patients with congenital heart defects. Arch Med Res 38:212–218CrossRefPubMed Galdieri LC, Arrieta SR, Silva CM et al (2007) Homocysteine concentrations and molecular analysis in patients with congenital heart defects. Arch Med Res 38:212–218CrossRefPubMed
10.
Zurück zum Zitat García-Fragoso L, García-García I, Leavitt G et al (2010) MTHFR polymorphisms in Puerto Rican children with isolated congenital heart disease and their mothers. Int J Genet Mol Biol 2(3):43–47PubMedCentralPubMed García-Fragoso L, García-García I, Leavitt G et al (2010) MTHFR polymorphisms in Puerto Rican children with isolated congenital heart disease and their mothers. Int J Genet Mol Biol 2(3):43–47PubMedCentralPubMed
11.
Zurück zum Zitat Goldmuntz E, Woyciechowski S, Renstrom D, Lupo PJ et al (2008) Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1(2):126–132PubMedCentralCrossRefPubMed Goldmuntz E, Woyciechowski S, Renstrom D, Lupo PJ et al (2008) Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1(2):126–132PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Henderson GI, Perez T, Schenker S et al (1995) Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med 126:184–203PubMed Henderson GI, Perez T, Schenker S et al (1995) Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med 126:184–203PubMed
13.
Zurück zum Zitat Hobbs CA, James SJ, Parsian A et al (2006) Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene. J Med Genet 43:162–166PubMedCentralCrossRefPubMed Hobbs CA, James SJ, Parsian A et al (2006) Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene. J Med Genet 43:162–166PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Hobbs CA, Cleves MA, Karim MA et al (2010) Maternal folate-related gene environment interactions and congenital heart defects. Obstet Gynecol 116(2 Pt 1):316–322PubMedCentralCrossRefPubMed Hobbs CA, Cleves MA, Karim MA et al (2010) Maternal folate-related gene environment interactions and congenital heart defects. Obstet Gynecol 116(2 Pt 1):316–322PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Huang J, Mei J, Jiang L et al (2014) MTHFR rs1801133 C > T polymorphism is associated with an increased risk of tetralogy of Fallot. Biomed Rep 2:172–176PubMedCentralPubMed Huang J, Mei J, Jiang L et al (2014) MTHFR rs1801133 C > T polymorphism is associated with an increased risk of tetralogy of Fallot. Biomed Rep 2:172–176PubMedCentralPubMed
16.
Zurück zum Zitat Junker R, Kotthoff S, Vielhaber H et al (2001) Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovas Res 51:251–254CrossRef Junker R, Kotthoff S, Vielhaber H et al (2001) Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovas Res 51:251–254CrossRef
17.
Zurück zum Zitat Linda Sharp, Little J (2004) Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: a HuGE Review. Am J Epidemiol 159:423–443CrossRef Linda Sharp, Little J (2004) Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: a HuGE Review. Am J Epidemiol 159:423–443CrossRef
18.
Zurück zum Zitat Lupo P, Goldmuntz E, Mitchell L (2010) Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotech 2010:1–7CrossRef Lupo P, Goldmuntz E, Mitchell L (2010) Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotech 2010:1–7CrossRef
19.
Zurück zum Zitat Marinho C, Alho I, Uerra A et al (2009) The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of fallot. Rev Port Cardiol 28(7–8):809–812PubMed Marinho C, Alho I, Uerra A et al (2009) The methylenetetrahydrofolate reductase gene variant (C677T) as a susceptibility gene for tetralogy of fallot. Rev Port Cardiol 28(7–8):809–812PubMed
20.
Zurück zum Zitat McBride KL, Fernbach S, Menesses A et al (2004) A family-based association study of congenital left-sided heart malformations and 5, 10 methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 70:825–830CrossRefPubMed McBride KL, Fernbach S, Menesses A et al (2004) A family-based association study of congenital left-sided heart malformations and 5, 10 methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 70:825–830CrossRefPubMed
21.
Zurück zum Zitat Nurk E, Tell GS, Refsum H et al (2004) Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med 117:26–31CrossRefPubMed Nurk E, Tell GS, Refsum H et al (2004) Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med 117:26–31CrossRefPubMed
22.
Zurück zum Zitat Pishva SR, Vasudevan R, Etemad A et al (2013) Analysis of MTHFR and MTRR gene polymorphisms in Iranian ventricular septal defect subjects. Int J Mol Sci 14:2739–2752PubMedCentralCrossRefPubMed Pishva SR, Vasudevan R, Etemad A et al (2013) Analysis of MTHFR and MTRR gene polymorphisms in Iranian ventricular septal defect subjects. Int J Mol Sci 14:2739–2752PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Shaw GM, Lammer EJ, Zhu H et al (2002) Maternal periconceptional vitamine use, genetic variation of infant reduced folate carrier (A80G) and risk of spina bifida. Am J Med Genet 108:1–6CrossRefPubMed Shaw GM, Lammer EJ, Zhu H et al (2002) Maternal periconceptional vitamine use, genetic variation of infant reduced folate carrier (A80G) and risk of spina bifida. Am J Med Genet 108:1–6CrossRefPubMed
24.
Zurück zum Zitat Shaw GM, Zhu H, Lammer EJ et al (2003) Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 158:747–752CrossRefPubMed Shaw GM, Zhu H, Lammer EJ et al (2003) Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 158:747–752CrossRefPubMed
25.
Zurück zum Zitat Shaw GM, Iovannisci DM, Yang W et al (2005) Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Gen 138A:21–26CrossRef Shaw GM, Iovannisci DM, Yang W et al (2005) Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Gen 138A:21–26CrossRef
26.
Zurück zum Zitat Storti S, Vittorini S, Iascone MR et al (2003) Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C Polymorphisms and conotruncal heart defects. Clin Chem Lab Med 41(3):276–280CrossRefPubMed Storti S, Vittorini S, Iascone MR et al (2003) Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C Polymorphisms and conotruncal heart defects. Clin Chem Lab Med 41(3):276–280CrossRefPubMed
27.
Zurück zum Zitat Storti S, Vittorini S, Lascone MR et al (2003) Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab 41:276–280 Storti S, Vittorini S, Lascone MR et al (2003) Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab 41:276–280
28.
Zurück zum Zitat Van Beynum IM, Kapusta L, Heijer MD et al (2006) Maternal MTHFR 677C > T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 27:981–987CrossRefPubMed Van Beynum IM, Kapusta L, Heijer MD et al (2006) Maternal MTHFR 677C > T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 27:981–987CrossRefPubMed
29.
Zurück zum Zitat Wenstrom KD, Johanning GL, Johnston KE et al (2001) Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstetrics and gynecology 184(5):806–817CrossRef Wenstrom KD, Johanning GL, Johnston KE et al (2001) Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstetrics and gynecology 184(5):806–817CrossRef
30.
Zurück zum Zitat Youssef OI, Sayed GME (2012) MTHFR 677 C → T polymorphism and the risk of cardiac septal defects: a pilot study. Life Sci J 9(4):4272–4275 Youssef OI, Sayed GME (2012) MTHFR 677 C → T polymorphism and the risk of cardiac septal defects: a pilot study. Life Sci J 9(4):4272–4275
31.
Zurück zum Zitat Zeng W, Liu L, Tong Y et al (2011) A66G and C524T polymorphisms of the methionine synthase reductase gene are associated with congenital heart defects in the Chinese Han population. Genet Mol Res 10(4):2597–2605CrossRefPubMed Zeng W, Liu L, Tong Y et al (2011) A66G and C524T polymorphisms of the methionine synthase reductase gene are associated with congenital heart defects in the Chinese Han population. Genet Mol Res 10(4):2597–2605CrossRefPubMed
32.
Zurück zum Zitat Zhu H, Yang W, Lu W et al (2012) Gene variants in the folate-mediated one-carbon metabolism (FOCM) pathway as risk factors for conotruncal heart defects. Am J Med Genet Part A 158A:1124–1134PubMedCentralCrossRefPubMed Zhu H, Yang W, Lu W et al (2012) Gene variants in the folate-mediated one-carbon metabolism (FOCM) pathway as risk factors for conotruncal heart defects. Am J Med Genet Part A 158A:1124–1134PubMedCentralCrossRefPubMed
Metadaten
Titel
The A1298C Methylenetetrahydrofolate Reductase Gene Variant as a Susceptibility Gene for Non-Syndromic Conotruncal Heart Defects in an Indian Population
verfasst von
Teena Koshy
Vettriselvi Venkatesan
Venkatachalam Perumal
Sridevi Hegde
Solomon Franklin Durairaj Paul
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2015
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-015-1188-3

Weitere Artikel der Ausgabe 7/2015

Pediatric Cardiology 7/2015 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.